Admission Date:  [**2113-2-17**]              Discharge Date:   [**2113-2-26**]  Date of Birth:  [**2054-1-15**]             Sex:   F  Service: MEDICINE  Allergies: Anzemet  Attending:[**First Name3 (LF) 6169**] Chief Complaint: febrile neurtropenia  Major Surgical or Invasive Procedure: None   History of Present Illness: 58 year old female with hypothyroidism, HTN, and recently diagnosed ALL(Precursor B-phenotype, [**Location (un) 5622**] chromosome negative) discharged recently after an admission from ([**2113-1-6**]- [**2113-1-26**]) after induction chemotherapy consisting of hyper-CVAD- cyclophosphamid, mesna, mtx, doxorubicin, vincristine, dexamethasone 40 mg/d dys [**12-22**] and [**11-1**].
She was then admitted from [**Date range (1) 93815**] for part B hyper CVAD and developed febrile neutropenia with fevers to 101.7 in the clinic.
She developed rhinorrhea and nasal congestion 2 days after being d/c'ed.
She was was started on antifungals receiving her first dose on [**2-17**] along with levofloxacin on [**2-19**] for atypical coverage.
On the day of transfer to the ICU pulmonary was consulted who recommended sending a DFA, sputum for PCP and [**Name9 (PRE) 93816**] treatment for PCP consisting of solumedrol and IV bactrim.
She was given 40mg IV lasix with net negative = 1070.
She was then transferred to the ICU for further managemtnt.
Her fungal coverage was discontinued.
She is currently on Levofloxacin/Cefepime as double coverage of GNR, and Vancomycin given GPC.
Past Medical History: 1) ALL, Precursor B-phenotype (Induction with Hyper-CVAD [**2113-1-7**], Negative for [**Location (un) 5622**] Chromosome) ONCOLOGIC HISTORY: Obtained from chart review: 58 yo female with a h/o hypothyroidism who presents for evaluation of possible ALL.
A central line was placed, an trans-thoracic ECHO was performed on admission.
Subsequently, induction chemotherapy with Hyper-CVAD was initiated on [**2113-1-7**].
Her right subclavian line was removed on [**1-20**].
On [**2113-2-3**], the patient received 12 mg of intrathecal methotrexate at 15 mg and intrathecal hydrocortisone and part B hyper CVAD.
2) Vancomycin SENSITIVE enterococcus faecium bacteremia during induction chemotherapy 3) Hypothyroidism 4) HTN   Social History: Unmarried, lives with her mother (85) and brother (64).
58 year old female with hypothyroidism, HTN, history of vancomycin sensitive enterococcus, and ALL (Precursor B-phenotype, [**Location (un) 5622**] chromosome negative) who was admitted for febrile neutropenia.
The patient's oxygen requirement worsened and she was transferred to the ICU for further monitoring.
The patient was on Cefepime, Vanc and Caspo.
On transfer to the ICU, Levofloxacin was added for double coverage of gram negatives.
She was also started on IV Bactrim with steroids for possible PCP [**Name Initial (PRE) 1064**].
Her Levofloxacin was discontinued and her Cefepime was changed to Ceftriaxone.
The patient was continued on Bactrim and steroids for presumed PCP [**Name Initial (PRE) 1064**].
Her Vancomycin and Ceftriaxone were discontinued.
The patient will continue Bactrim and Prednisone to complete a 21 day course for treatment of PCP [**Name Initial (PRE) 1064**].
# Febrile Neutropenia: Given her history of vancomycin sensitive enterococus, the patient was continued on Vancomycin and started on Cefepime.
She was given Neulasta as an outpatient.
She was initially covered with Levofloxacin and Cefepime given the GNR in her sputum culture but per micro lab these were consistent with normal oral flora.
Caspofungin was added when the patient began to have worsening respiratory function.
Additionally, Bactrim was started for concern of PCP.
[**Name10 (NameIs) 616**] transfer back to the BMT service, Levo and Cefepime were discontinued.
The patient was continued on Bactrim and Vancomycin and switched to Ceftriaxone.
She completed Ceftriaxone x 7 days.
She will be treated for a total 21 day course of Bactrim for presumed PCP [**Name Initial (PRE) 1064**].
The patient had gotten Neulasta as an outpatient and additionally was started on IV Methylpred in the MICU and continued on Prednisone for treatment of PCP [**Name Initial (PRE) 1064**].
She receieved intrathecal MTX and intrathecal hydrocortisone on [**2113-2-3**].
# HTN: Hydralazine was continued as per outpatient regimen.
# Prophylaxis: She was discharged on Acyclovir for ppx.
Her Fluconazole and Levofloxacin were discontinued given that she was no longer neutropenic.. .
Medications on Admission: Levothyroxine 75 mcg PO daily Hydralazine 25 mg PO Q6 levofloxacin 500 mg PO daily Fluconazole 200 mg PO BID ertapenem IV daily x 1 week   Discharge Medications: 1.
Trimethoprim-Sulfamethoxazole 160-800 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day) for 14 days.
Heparin Flush (10 units/ml) 5 ml IV PRN 3.
Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Hydralazine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours).
Prednisone 10 mg Tablet Sig: Three (3) Tablet PO once a day for 3 days.
Prednisone 10 mg Tablet Sig: Two (2) Tablet PO once a day for 11 days: Please start after you complete the Prednisone 30mg daily for 3 days.
Acyclovir 400 mg Tablet Sig: One (1) Tablet PO twice a day.
Discharge Condition: Good: On room air, ambulating independently, taking good PO intake   Discharge Instructions: Please take all medications as prescribed.
The following changes were made in your medication regimen: - You were started on two new medications for PCP pneumonia, Bactrim and Prednisone and you should continue to take these medications for 14 more days after your discharge.
- You were also started on Acyclovir for prevention of HSV.
- You may stop taking Levofloxacin and Fluconazole now that your WBC has come back up.
